Harmony Biosciences Holdings, Inc. HRMY Business Segments — Interest Expense Nonoperating
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s business segments — interest expense nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s business segments — interest expense nonoperating?
- Harmony Biosciences Holdings, Inc. (HRMY) reported business segments — interest expense nonoperating of $3.23M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s business segments — interest expense nonoperating changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s business segments — interest expense nonoperating decreased by 15.7% year-over-year, from $3.84M to $3.23M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s business segments — interest expense nonoperating?
- Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s business segments — interest expense nonoperating has grown at a -8.0% compound annual growth rate (CAGR), from $18.8M to $14.65M.
- What does business segments — interest expense nonoperating mean?
- This represents the cost of servicing debt obligations that are not directly tied to the primary operational activities of the segment. It provides insight into the financial leverage and the cost of capital utilized to fund the company's broader business activities.